Clinical Trial Update: Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating caspofungin as antifungal prophylaxis in high-risk liver transplant recipients to prevent fungal infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungemia
• Mycoses

Drugs mentioned

• Cancidas (caspofungin)

Snippet

Sponsor: Azienda Ospedaliera di Padova | Conditions: Fungemia, Mycoses | Phase 2 | Status: UNKNOWN